TipRanks
JXUE
JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF Accum- EUR
Advertisement

IT:JXUE ETF Price & Analysis

Compare

JXUE ETF Chart & Stats

€22.09
--
Market closed
€22.09
--

ETF Overview

JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF Accum- EUR

JPMorgan ETFs (Ireland) ICAV – Global ex US Research Enhanced Index Equity Active UCITS ETF Accum (EUR) is an actively managed, UCITS‑regulated exchange‑traded fund designed to provide broad, long‑term exposure to the global equity market outside the United States while seeking to outperform its benchmark through research‑driven stock selection and portfolio construction. What it does - Provides diversified exposure to equities across developed and emerging markets excluding the US, covering a wide range of market capitalizations (total‑market orientation). - Combines a broad, core equity footprint with an active “research enhanced” approach: proprietary quantitative and fundamental research informs stock selection, factor tilts and portfolio weights with the aim of generating incremental return versus the benchmark. - Operates within an index‑aware, actively managed framework that seeks to balance the pursuit of excess return with controls on tracking error and overall portfolio risk. Key features - Broad‑based, total‑market focus outside the US: offers a single ETF solution for investors wanting a core international equity allocation without US exposure. - Size and style emphasis: research inputs can create deliberate size and style exposures (e.g., small/large cap and growth/value insights) across the total market to enhance return potential. - Accumulating (EUR) share class: income from holdings is reinvested into the fund, supporting compounding and long‑term capital growth; denominated in euros. - UCITS structure and Ireland domicile: provides investor protections and standardised governance and diversification limits expected of UCITS funds. Who it’s for - Investors seeking a core non‑US equity allocation but wanting an actively‑managed, research‑driven strategy rather than passive replication. - Suitable for long‑term investors prioritising capital growth and willing to accept the additional active risk that comes with attempts to outperform a benchmark. Risks and considerations - Exposes investors to market, currency and country risks outside the US; performance may diverge from plain index replication due to active decisions and factor tilts. - As an active ETF, potential for tracking error and periods of underperformance versus the benchmark should be expected. In short, JXUE aims to deliver broad, non‑US equity market coverage while using JPMorgan’s research capabilities to enhance returns—making it a convenient, single‑ticket solution for investors seeking an actively managed international equity sleeve outside the United States.

JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF Accum- EUR (JXUE) Fund Flow Chart

JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF Accum- EUR (JXUE) 1 year Net Flows: €142K

JXUE ETF News

JXUE ETF FAQ

What was IT:JXUE’s price range in the past 12 months?
IT:JXUE lowest ETF price was €21.61 and its highest was €23.22 in the past 12 months.
    What is the AUM of IT:JXUE?
    As of Oct 13, 2026 The AUM of IT:JXUE is 582.71K.
      Is IT:JXUE overvalued?
      According to Wall Street analysts IT:JXUE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does IT:JXUE pay dividends?
        IT:JXUE does not currently pay dividends.
        How many shares outstanding does IT:JXUE have?
        Currently, no data Available
        Which hedge fund is a major shareholder of IT:JXUE?
        Currently, no hedge funds are holding shares in IT:JXUE

        Top 10 Holdings

        Name
        Weight %
        ASML Holding NV
        3.30%
        Siemens Ag (UK)
        1.54%
        AstraZeneca plc
        1.46%
        Shell plc (UK)
        1.32%
        Allianz SE (UK)
        1.31%
        Hsbc Holdings Plc (UK)
        1.26%
        Banco Santander SA
        1.25%
        Roche Holding
        1.20%
        Tokyo Electron
        1.13%
        Nestlé
        1.12%
        Total14.88%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Advertisement